STOCKHOLDERS' EQUITY - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended	12 Months Ended				1 Months Ended							1 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended		1 Months Ended		12 Months Ended	1 Months Ended	12 Months Ended		1 Months Ended		12 Months Ended				1 Months Ended
	May 11, 2010	Feb. 29, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 Convertible Debt	Dec. 31, 2012 Secured Debt	Jun. 28, 2012 Directors and Officers	Jun. 06, 2011 Directors and Officers	Jun. 06, 2011 Three Independent Members Of The Board Of Directors	Jun. 06, 2011 Two Executive Officers	Dec. 01, 2012 Three Officers	Dec. 31, 2011 Minimum	Dec. 31, 2011 Maximum	Jul. 31, 2012 Investor Relations Consultant Restricted Stock	Dec. 31, 2012 Investor Relations Consultant Restricted Stock	Aug. 31, 2012 Business Development Consultant Restricted Stock	Dec. 31, 2012 Each Consultant	Dec. 31, 2012 Total Consultant	May 31, 2012 Mr Mckay and Celebrity Foods	May 31, 2012 Attorney Of Mr Mckay and Celebrity Foods	Dec. 31, 2012 Tri-Med Corporation	May 31, 2012 Common Stock	Dec. 31, 2012 Common Stock	Dec. 31, 2011 Common Stock	Dec. 31, 2011 Common Stock Settlement of legal dispute	Aug. 31, 2011 Common Stock Settlement of legal dispute	Dec. 31, 2011 Common Stock Settlement of legal dispute	Dec. 31, 2012 Series D Warrants	Dec. 31, 2011 Series D Warrants	Dec. 31, 2011 Charles Rufai	Sep. 30, 2011 John Bergeron
Stockholders Equity [Line Items]
Stock Issued During Period Shares Restricted Stock Award Net of Forfeitures	500,000		557,486																											25,000	100,000
Issuance of common stock for compensation of employees				$ 94,000																				$ 100							$ 94,000
Cancellation of common stock (in shares)																									515,000	515,000	(515,000)
Short-term Debt, Average Outstanding Amount																														23,900
Shares Underlying Warrants			1,002,778		69,445	333,333																						400,000	400,000
Fair Vallue Warrants Issued Weighted Average Price Range												$ 0.57	$ 0.74
Warrants issued for debt costs associated with sale of debentures			0	279,000																									279,000
Debt cost			0	167,386																								167,386	55,786
Interest expense other																												111,600	111,614
Weighted-average estimated fair value of the options granted			408,000	696,750
Compensation expense			300,000	171,585
Unrecognized compensation expense related to non-vested stock option awards			482,110
Common stock, par value			$ 0.001	$ 0.001										$ 1.14	$ 0.54	$ 1.05		$ 0.54	$ 1.39
Compensation expense to be recognized in last quarter			122,110
Compensation expense last recognized date			Dec. 31, 2014
Options granted, Shares Underlying Options			617,582				150,000	975,000	75,000	900,000	600,000
Issuance of common stock for acquisition of assets of Gleric Holdings, LLC (See Note 4) (in shares)																						170,000	170,000
Class of detachable warrant			69,445
Weighted Average Grant Date Fair Value							$ 1.15		$ 0.65	$ 0.72	$ 0.46
Commons stock retain By investor																			448,000
Issuance of restricted common stock																			135,000	100,000			235,000
Restricted shares of common stock														15,000	30,000	300,000	10,000	20,000					365,000
Class of warrant or right shares issued																					69,445
Purchase price, shares											200,000
Exercise price											$ 0.54
Shares of stock expried period											2 years
Fair value of the options forfeited			151,055
Number Of Officers									3
Share based compensation arrangement by share based payment award options vest term											5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period											2 years
Due to related parties		$ 1,020,200	$ 352,909	$ 1,330,899
Number Common Stock issued in exchange Of convertible debt		557,486																					557,486